Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Rare Cannabinoid Company Publishes Expanded CBN vs. CBD Sleep Guide Featuring Human Research

Rare Cannabinoid Company logo

News provided by

Rare Cannabinoid Company

Oct 20, 2026, 09:56 ET

Share this article

Share toX

Share this article

Share toX

Updated guide explores falling asleep, nighttime awakenings and next-day fatigue, plus melatonin-free CBN sleep gummies and oils with and without THC

HONOLULU, Oct. 20, 2026 /PRNewswire/ -- What is the difference between CBN and CBD for sleep? Can nighttime cannabinoids support restful sleep without added melatonin? Rare Cannabinoid Company answers these questions in its substantially expanded CBN vs. CBD for sleep guide. The guide explains human sleep research in plain language and helps readers compare cannabinoid amounts, product formats and melatonin-free nighttime options.

Continue Reading
Rare Cannabinoid Company’s melatonin-free CBN Sleep Gummies contain 30 mg CBN and 10 mg CBD per gummy, with zero THC, and are featured in its expanded CBN vs. CBD sleep guide.
Rare Cannabinoid Company’s melatonin-free CBN Sleep Gummies contain 30 mg CBN and 10 mg CBD per gummy, with zero THC, and are featured in its expanded CBN vs. CBD sleep guide.

The updated resource introduces CBN, or cannabinol, as a sleep-focused cannabinoid and CBD, or cannabidiol, as a popular ingredient for calm and relaxation. The guide compares three melatonin-free nighttime formulas: a pure CBN oil, CBN sleep gummies with CBD, and CBN-and-CBD gummies with added THC.

Key takeaways from the expanded guide

  • Human CBN research offers encouraging sleep findings: Trials have reported fewer nighttime awakenings and, at a higher studied dose, faster sleep onset.
  • Next-day experience matters: A seven-night trial found reduced nighttime awakenings without increased daytime fatigue.
  • Nighttime formulas offer different experiences: Consumers can choose CBN alone, paired with CBD, or combined with CBD and THC.
  • Melatonin is a separate ingredient: Rare Cannabinoid Company's nighttime products contain no added melatonin.

Human research brings CBN sleep benefits into focus

A randomized, double-blind, placebo-controlled trial published in Experimental and Clinical Psychopharmacology in 2024 analyzed 293 adults with poor self-rated sleep. Participants receiving 20 mg CBN experienced significantly fewer nighttime awakenings and less overall sleep disturbance than those receiving placebo, without increased daytime fatigue.

A 2026 sleep-laboratory trial adds encouraging findings on falling asleep. Published in the August 2026 issue of Journal of Sleep Research , the randomized crossover study compared CBN with placebo in 20 adults. A single 300 mg CBN dose helped participants fall asleep faster and improved their perceived sleep quality on secondary measures. The study's main measure—time awake after initially falling asleep—did not significantly change. The guide explains the research dose and how it differs from the amounts in retail products.

Explore melatonin-free CBN oils and gummies

The guide compares three Rare Cannabinoid Company nighttime formulas:

  • CBN Rest Oil : A sugar-free, flavorless formula containing 500 mg CBN per bottle in certified organic MCT coconut oil, without THC.
  • CBN Sleep Gummies : Each vegan, huckleberry-flavored gummy contains 30 mg CBN and 10 mg CBD, with zero THC.
  • THC + CBN Sleep Gummies : Each vegan, huckleberry-flavored gummy contains 30 mg CBN, 10 mg CBD and 5 mg hemp-derived delta-9 THC. 

All three contain no added melatonin. Clearly labeled cannabinoid amounts and accessible batch reports help consumers compare ingredients and formats. The research discussed in the guide examined study preparations rather than these finished products.

CBN vs. CBD: common questions answered:

What is the difference between CBN and CBD?

CBN and CBD are separate cannabinoids found in hemp and cannabis. CBN is increasingly studied for sleep and commonly featured in nighttime products. CBD is widely used for calm and relaxation during the day or evening.

Can CBN and CBD be taken together?

Yes. Combined formulas provide both cannabinoids in one measured serving. Consumers can also choose pure CBN oil when they prefer a simpler formula.

Does a CBN product have to contain THC?

No. CBN can be formulated without THC. For adults who enjoy THC's dreamy, euphoric effects, THC-containing options offer a different nighttime experience. THC can cause intoxication.

Is CBN the same as melatonin?

No. CBN is a cannabinoid; melatonin is a hormone involved in sleep-wake timing. Checking the complete ingredients helps consumers distinguish cannabinoid formulas from products that also contain added melatonin.

Readers can explore Rare Cannabinoid Company's CBN sleep gummies and oils to compare nighttime options with and without THC.

About Rare Cannabinoid Company

Rare Cannabinoid Company is a Honolulu-based hemp wellness brand specializing in rare cannabinoids, including CBN, CBG, CBC, THCV and CBDV. Its range includes gummies, oil tinctures and topicals, with clearly labeled cannabinoid amounts and third-party laboratory reports.

SOURCE Rare Cannabinoid Company

21%

more press release views with 
Request a Demo

Modal title

Also from this source

Rare Cannabinoid Company Shares Guide to Reading CBD and THC Lab Tests and Hemp Product Labels

Rare Cannabinoid Company Shares Guide to Reading CBD and THC Lab Tests and Hemp Product Labels

Rare Cannabinoid Company is sharing an educational guide to help consumers understand hemp product labels and third-party cannabinoid lab reports....

New Menopause Guide Explores How Women Are Using CBD, THC and CBN for Sleep, Mood and Everyday Wellness

New Menopause Guide Explores How Women Are Using CBD, THC and CBN for Sleep, Mood and Everyday Wellness

As more women explore cannabis and hemp-derived cannabinoids during perimenopause and menopause, Rare Cannabinoid Company has published a...

More Releases From This Source

Explore

Supplementary Medicine

Supplementary Medicine

Cannabis

Cannabis

Health Care & Hospitals

Health Care & Hospitals

Surveys, Polls and Research

Surveys, Polls and Research

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content

About

  • About PR Newswire
  • About Cision
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2026 Cision US Inc.